Found 26 matching trials
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency PHASE3 Background. Treatment with intravenous iron has been shown to improve sympt...
Show More Location
Hospital de Clínicas de Porto Alegre
Learn More & Join Trial
Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle Dysfunction PHASE3 A significant reduction in the incidence of CV death or hospitalization for...
Show More Location
Beni-suef University
Learn More & Join Trial
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight PHASE2 Obesity is a medical condition which increases the risk of other diseases, ...
Show More Location
Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University and Section for Diabetes and Endocrinology at the Uppsala University Hospital
Learn More & Join Trial
Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes PHASE4 Dapagliflozin is a member of the sodium-glucose cotransporter-2 (SGLT2) inh...
Show More Location
University Hospital of Palermo
Learn More & Join Trial
Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus. PHASE3 The purpose of this study is to evaluate the efficacy and safety of Lima as...
Show More Location
Multiple Locations
Learn More & Join Trial
Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablets NA The study was an open-label, randomized, single-dose, two-period, two-seque...
Show More Location
PT Equilab International
Learn More & Join Trial
Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg PHASE1 The study is to compare the rate and extent of absorption of a generic form...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome PHASE3 In PCOS (Polycystic Ovary Syndrome), studies have found impaired incretin s...
Show More Location
October 6 University Hospital
Learn More & Join Trial
Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial PHASE2 Type 2 diabetes mellitus (T2DM) is a well-recognized independent risk facto...
Show More Location
Multiple Locations
Learn More & Join Trial
DapagliFLOzin in Renal AL Amyloidosis (FLORAL) PHASE2 The goal of this clinical trial is to learn if an oral drug called dapaglif...
Show More Location
Karmanos Cancer Institute
Learn More & Join Trial